论文部分内容阅读
《中华人民共和国药品管理法》(以下简称《药品管理法》)于今年2月28日,由九届全国人大常委会第二十次会议修订后公布,并将自今年12月1日起施行。3月7日,本刊记者就《药品管理法》修订的有关问题采访了中国全国人大常委会法制工作委员会副主任卞耀武。卞耀武副主任1960年毕业于上海社会科学院法律系,之后长期从事经济工作。1990年,卞耀武调任中国国家工商行政管理局任常务副局长,1992年,到中国全国人大常委会法制工作委员会任副主任,从事经济立法工作。虽然春寒料峭的北京正值全国人大和全国政协‘两会’期间,卞耀武副主任还是在百忙中抽出时间接受本刊采访,一一回答了记者的提问。
The Drug Administration Law of the People’s Republic of China (hereinafter referred to as the “Drug Administration Law”) was announced on February 28 this year after it was revised at the 20th meeting of the Ninth National People’s Congress Standing Committee (NPC), and will come into force on December 1 this year . On March 7, our correspondent interviewed Bian Yaowu, deputy director of the Legislative Affairs Working Committee of the Standing Committee of the Chinese National People’s Congress, on the revision of the Drug Administration Law. Bian Yaowu, Deputy Director Graduated from the Faculty of Law, Shanghai Academy of Social Sciences in 1960, and has long been involved in economic work. In 1990, Bian Yaowu was transferred to the executive deputy director of the State Administration for Industry and Commerce of China. In 1992, he served as the deputy director of the legal work committee of the Standing Committee of the Chinese National People’s Congress and engaged in economic and legislative work. Although the chill season of Beijing coincided with the NPC and the CPPCC ’two sessions’, Bian Yaowu, deputy director or out of his busy schedule to accept the interview, one by one to answer questions from reporters.